Mack WJ - Search Results

1

Efficacy of two lipid-lowering treatments on quantitative coronary angiographic endpoints.

Mack WJ, Xiang M, Shircore AM, Selzer RH, Hodis HN, Azen SP. Mack WJ, et al. Cardiovasc Drugs Ther. 2000 Aug;14(4):411-8. doi: 10.1023/a:1007816300468. Cardiovasc Drugs Ther. 2000. PMID: 10999648 Clinical Trial.

2

The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.

Cashin-Hemphill L, Kramsch DM, Azen SP, DeMets D, DeBoer LW, Hwang I, Vailas L, Hirsch LJ, Mack WJ, DeBoer L, et al. Cashin-Hemphill L, et al. Among authors: mack wj. Online J Curr Clin Trials. 1992 Oct 23;Doc No 26:[9897 words; 83 paragraphs]. Online J Curr Clin Trials. 1992. PMID: 1343613 Clinical Trial.

3

Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures. A comparison of different measures of treatment effect.

Blankenhorn DH, Selzer RH, Mack WJ, Crawford DW, Pogoda J, Lee PL, Shircore AM, Azen SP. Blankenhorn DH, et al. Among authors: mack wj. Circulation. 1992 Dec;86(6):1701-9. doi: 10.1161/01.cir.86.6.1701. Circulation. 1992. PMID: 1451241

4

Comparison of computer- and human-derived coronary angiographic end-point measures for controlled therapy trials.

Mack WJ, Selzer RH, Pogoda JM, Lee PL, Shircore AM, Azen SP, Blankenhorn DH. Mack WJ, et al. Arterioscler Thromb. 1992 Mar;12(3):348-56. doi: 10.1161/01.atv.12.3.348. Arterioscler Thromb. 1992. PMID: 1547194 Clinical Trial.

5

Evaluation of human panelists in assessing coronary atherosclerosis.

Azen SP, Cashin-Hemphill L, Pogoda J, Mack WJ, Sanmarco ME, Wickham E, Blankenhorn DH. Azen SP, et al. Among authors: mack wj. Arterioscler Thromb. 1991 Mar-Apr;11(2):385-94. doi: 10.1161/01.atv.11.2.385. Arterioscler Thromb. 1991. PMID: 1998656 Clinical Trial.

6

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.

Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH. Cashin-Hemphill L, et al. Among authors: mack wj. JAMA. 1990 Dec 19;264(23):3013-7. JAMA. 1990. PMID: 2243429 Clinical Trial.

7

Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial.

Shircore AM, Mack WJ, Selzer RH, Lee PL, Azen SP, Alaupovic P, Hodis HN. Shircore AM, et al. Among authors: mack wj. Circulation. 1995 Nov 1;92(9):2411-8. doi: 10.1161/01.cir.92.9.2411. Circulation. 1995. PMID: 7586339 Clinical Trial.

8

Triglyceride-rich lipoproteins and the progression of coronary artery disease.

Hodis HN, Mack WJ. Hodis HN, et al. Among authors: mack wj. Curr Opin Lipidol. 1995 Aug;6(4):209-14. doi: 10.1097/00041433-199508000-00004. Curr Opin Lipidol. 1995. PMID: 7670749 Review.

9

Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis.

Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azen SP. Hodis HN, et al. Among authors: mack wj. JAMA. 1995 Jun 21;273(23):1849-54. JAMA. 1995. PMID: 7776501 Clinical Trial.

10

Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images.

Selzer RH, Hodis HN, Kwong-Fu H, Mack WJ, Lee PL, Liu CR, Liu CH. Selzer RH, et al. Among authors: mack wj. Atherosclerosis. 1994 Nov;111(1):1-11. doi: 10.1016/0021-9150(94)90186-4. Atherosclerosis. 1994. PMID: 7840805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

660 results

Search Page

Filters